Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 210 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol 400 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol 400 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Ipratropium and salbutamol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Ipratropium- and salbutamol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Ipratropium bromide 200 microgram/mL and salbutamol (as salbutamol sulfate) 1 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Choline theophyllinate 20 mg/mL and salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing salbutamol and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing only salbutamol and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Salbutamol and theophylline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Product containing salbutamol and theophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol |
Inferred relationship |
Some |
2 |
Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 1 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 200 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol |
Inferred relationship |
Some |
1 |